Clinical Trial: BIOSTEMI Extended Survival
Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Condition:
Coronary Artery Disease
Acute Coronary Syndrome
Study Type: Observational
Official Title: Randomized Multicenter Comparison Between Ultrathin-strut Biodegradable Polymer Sirolimuseluting Stents and Durable Polymer Everolimus-eluting Stents for Patients With Acute ST-segment Elevation Myoca
Brief Summary:
The objective of the BIOSTEMI ES study is to assess the long-term clinical outcomes with the Orsiro ultrathin-strut biodegradable polymer sirolimus-eluting stent compared to the Xience thin-strut durable polymer everolimus-eluting stent up to 5 years of follow-up among patients with STEMI undergoing primary PCI, enrolled in the BIOSTEMI trial.
Read more